ocular
viral
infect
manifest
selv
varieti
clinic
pictur
commonli
clinician
find
follicular
con
junctiv
without
accompani
kerat
epitheli
subepitheli
corneal
infiltr
frequent
observ
adenovrru
mwnon
hut
also
occur
hprppg
simpw
nfhpr
sriraijnduc
kerajilisia
ction
addit
keratoconjunct
virus
directli
directli
caus
deep
ocular
involv
clude
uveiti
optic
nerv
inflamma
tion
effort
learn
etiolo
gie
ocular
viral
infect
pathogenesi
viral
kerat
studi
two
group
patient
epidem
nonepidem
viral
infect
follicular
conjunct
mani
suffer
kerat
least
one
stage
ill
three
major
goal
determin
rate
viral
recoveri
case
nonepidem
acut
subacut
follicular
conjunc
tiviti
compar
accuraci
clinic
diagnos
achiev
cultur
serolog
studi
explor
possibl
role
serum
antibodi
forma
tion
mainten
corneal
subepitheli
infiltr
examin
one
group
patient
involv
epidem
caus
singl
viral
agent
second
group
patient
infect
mani
differ
ent
virus
result
indic
varieti
agent
caus
similar
ill
pattern
clinic
observ
alway
distinguish
one
anoth
furthermor
serolog
test
accur
diagnost
method
clinic
cours
ocular
viral
ill
case
system
viral
ill
final
viral
anti
bodi
titer
may
correl
directli
spe
cific
clinic
chang
adenovirusinduc
keratoconjunct
patientsw
studi
two
group
pa
tient
follow
method
first
popul
industri
employe
epidem
keratoconjunct
patient
describ
detail
elsewher
data
concern
ocular
find
present
second
group
patient
compris
heterogen
popul
seen
period
criterion
se
lection
follicular
conjunct
nine
patient
seen
emerg
room
clinic
staff
offic
barn
ho
pital
novemb
decemb
nine
follow
nation
eye
institut
juli
june
one
us
hlsk
saw
everi
patient
acut
subacut
phase
ill
follow
sign
symptom
abat
male
femal
rang
age
year
old
mean
year
twentynin
patient
black
white
two
orient
ambulatori
good
health
collect
viru
cultur
specimensfiftyeight
nonepidem
patient
viral
cultur
cotton
swab
roll
inferior
culdesac
transfer
carrier
medium
sodium
chlorid
pota
sium
chlorid
dipotassium
phosphat
char
coal
agar
ph
content
tube
either
store
short
period
immedi
transfer
tissu
cultur
tube
human
diploid
fibroblast
primari
human
embryo
kidney
cell
human
epidermoid
carcinoma
stan
dard
cultur
method
describ
previous
virus
isol
initi
attempt
pass
compar
ref
erenc
prototyp
viru
strain
indic
atyp
method
viral
cultur
epidem
keratoconjunct
patient
describ
elsewher
singl
patient
cultur
trachoma
inclus
con
junctiv
tric
agent
meth
od
serolog
studiesof
origin
studi
patient
return
convalesc
serum
therefor
serolog
result
base
patient
collect
sera
dur
ing
acut
phase
twice
convalesc
phase
two
famili
group
specimen
one
uninf
ect
member
consid
acut
anoth
infect
member
specimen
consid
convalesc
took
con
valesc
specimen
pa
tient
within
day
initi
visit
within
day
three
patient
speci
men
separ
day
sera
test
antibodi
prototyp
strain
mani
respiratori
virus
order
survey
like
caus
follicular
conjunct
tabl
complementfix
hemagglutinationinhibit
indirect
hemagglutin
serum
neutral
test
employ
appropri
particular
viru
sera
heatinactiv
minut
serolog
test
antibodi
influenza
b
c
parainfluenza
mump
viru
viral
antigen
rubeola
respiratori
syncyti
viru
rs
v
coronaviru
herp
simplex
varicella
mycoplasma
pneumonia
bedsonia
tric
agent
cytomegaloviru
adeno
viru
groupspecif
hexonantigen
say
standard
complementfixa
tion
test
overnight
fixat
unit
complement
antibodi
influenza
b
parainfluenza
newcastl
diseas
viru
mump
viru
rubeola
coronaviru
vaccinia
adenoviru
type
assay
standard
hemagglutinationinhibit
test
phosphatebuff
salin
diluent
spectrophotometr
standard
ize
mammalian
avian
red
blood
cell
antibodi
coronaviru
addit
measur
indirect
hemagglutin
test
neutral
anti
bodi
rubeola
rs
v
select
adenovirus
six
coxsacki
b
virus
echoviru
type
coxsackieviru
assay
serum
neutral
test
human
epidermoid
carcinoma
monkey
kidney
tissu
cultur
neutral
vol
viral
keratoconjunct
antibodi
titer
vaccinia
herp
coxsackieviru
four
strain
acut
hemorrhag
conjunct
viru
similarli
assay
serum
neutraliza
tion
test
human
diploid
fibroblast
tissu
cultur
serum
neutral
antibodi
coxsackieviru
assay
suckl
mous
brain
diagnost
purpos
fourfold
titer
chang
either
rise
fall
consid
ere
signific
serolog
test
addit
stabl
titer
serolog
test
hemagglutinationinhibit
serum
neutral
complementfixa
tion
suggest
infect
agent
clinic
cours
serolog
test
confirmatori
serolog
comparison
carri
adenoviru
group
describ
test
done
stan
dardiz
manner
use
hemag
glutinationinhibit
test
pho
phatebuff
salin
standard
mam
malian
avian
red
blood
cell
compar
adenoviru
type
antigen
type
maintain
center
diseas
control
use
similar
serolog
studi
past
serolog
test
sult
enter
calcul
signific
titer
level
test
sera
simultan
duplic
cell
lot
whenev
possibl
test
ing
condit
result
would
equiv
alent
clinic
examinationsthos
patient
epidem
keratoconjunct
ex
amin
initi
phase
ill
ness
approxim
one
month
re
olut
symptom
visual
acuiti
cord
slitlamp
microscopi
made
determin
presenc
absenc
subepitheli
infiltr
tempt
quantit
judg
sever
iti
patient
nonepidem
group
treat
differ
manner
pa
tient
seen
least
twice
evalu
subject
object
evid
ocu
lar
ill
examin
tempt
document
sever
symptom
visual
acuiti
presenc
preauricular
node
adenopathi
appear
anc
conjunctiva
cornea
anterior
chamber
slitlamp
microscopi
detail
draw
cornea
made
kerat
case
exact
number
lesion
record
instead
attempt
depict
accur
area
cornea
volv
futur
evalu
patient
follow
kerat
show
sign
stabil
actual
regress
possibl
patient
persist
lesion
follow
longer
time
period
end
studi
period
draw
reexamin
pa
tient
estim
percentag
cornea
involv
infiltr
peak
phase
ill
assign
valu
fore
serolog
data
avail
serolog
complet
adeno
viru
group
investig
separ
calcul
sever
kerat
vs
sero
logic
titer
hemagglutinationinhibit
test
valu
percentag
corneal
involv
ment
arriv
previous
therapeut
regimenalmost
patient
treat
topic
antibiot
compress
astring
two
pa
tient
adenoviru
group
receiv
corticosteroid
cessat
acut
phase
visual
acuiti
decreas
pa
tient
herp
group
given
variou
antivir
prepar
although
gener
effect
control
acut
diseas
attempt
statist
corr
lation
determin
efficaci
ancillari
studiesw
took
swab
rou
tine
bacteri
cultur
nonepidem
pa
tient
simultan
viral
cultur
although
taken
ran
dom
occasion
patient
present
sign
symptom
suggest
bacteri
conjunct
complic
viral
ill
patient
cultur
specif
identifi
possibl
infecti
agent
addi
tion
conjunctiv
scrape
examin
american
journal
ophthalmolog
octob
patient
process
giemsa
gram
stain
tear
studiestear
collect
ten
patient
acut
chronic
nonepidem
viral
infect
chronic
noninfecti
conjunct
detail
collect
ing
process
quantit
immunoglobulin
tear
describ
pre
viousli
viral
serolog
studi
tear
specimen
similar
done
sera
individu
tear
specimen
heatinactiv
dilut
start
instead
studi
involv
epidem
keratoconjunct
group
de
scribe
previous
although
infect
eye
cultur
yield
posit
viral
cul
ture
low
tabl
show
differ
number
posit
isol
ob
tain
cultur
eighth
data
epidem
keratoconjunc
tiviti
group
publish
elsewher
except
corneal
quantit
materi
clinic
studi
day
ill
cultur
viru
tend
di
appear
first
week
ill
viru
group
examin
adenoviru
isol
type
typic
prototypelik
strain
three
adenoviru
type
virus
neutral
inhibit
less
well
prototyp
refer
antisera
patient
convalesc
serum
clinic
signific
serolog
studi
nonepidem
patient
sinc
posit
viral
cultur
spars
restrospect
studi
acut
conval
cent
sera
constitut
major
mean
diag
nosi
cultur
posit
clinic
evid
point
specif
diagnosisth
presenc
herpet
dendritesth
total
bat
teri
serolog
test
tabl
al
way
carri
compar
clinic
serolog
diagnos
patient
whose
sera
examin
tabl
patient
posi
tive
cultur
show
expect
serolog
chang
two
patient
appear
ex
perienc
infect
two
agent
either
simultan
close
tempor
proxim
iti
one
patient
hemagglutinationinhibit
titer
adenoviru
type
stabl
indic
recent
infect
time
cultur
tric
agent
posit
second
patient
ill
ness
character
initi
upper
respiratori
infect
secondari
chronic
uniocular
kerat
comeal
ulcer
recur
renc
three
month
observ
chronic
phase
develop
gradual
fourfold
rise
adenoviru
type
hemagglutinationinhibit
antibodi
almost
eight
month
initi
ill
demonstr
sign
terior
uveiti
upper
respiratori
ill
ness
nonspecif
increas
herp
simplex
antibodi
titer
fourfold
complementfix
serum
neutral
test
data
sup
port
premis
doubl
infect
patient
five
addit
patient
demonstr
serovol
viral
keratoconjunct
logic
chang
suggest
either
sequenti
simultan
infect
two
three
agent
howev
patient
could
differenti
clinic
among
variou
agent
therefor
serolog
best
fit
clinic
pictur
time
sequenc
infect
chosen
final
diagnosi
clinic
misdiagnos
made
case
presum
epidem
keratoconjunct
adenoviru
type
promin
masquerad
herp
simplex
pass
epidem
keratoconjunct
one
case
list
geometr
mean
titer
major
adenoviru
group
encount
studi
tabl
although
averag
foldris
geometr
mean
titer
simi
lar
final
absolut
titer
differ
twofold
differ
sta
tistic
signific
attempt
explain
higher
final
titer
group
adenovirusinfect
pa
tient
look
two
differ
factor
first
consider
possibl
differ
enc
acut
convalesc
phase
se
rum
sampl
tabl
two
group
similar
makeup
nine
group
patient
ten
group
examin
acut
phase
ill
show
fourfold
rise
titer
infect
adenoviru
moder
dispar
patient
histori
serolog
data
three
group
patient
case
claim
ill
day
titer
reflect
longterm
ill
initi
chang
time
ob
serv
one
patient
case
un
chang
titer
throughout
ill
could
explain
lack
chang
titer
dispar
less
evid
group
case
differ
acut
phase
geometr
titer
group
nearli
signific
p
howev
con
sider
patient
proven
acut
phase
differ
signifi
cant
vs
p
differ
number
day
acut
convalesc
sampl
two
group
overal
mean
num
ber
day
group
group
signific
howev
patient
acut
phase
consid
averag
day
day
respect
p
df
data
higher
titer
expect
group
caus
longer
interv
acut
phase
serum
peak
thu
neither
titer
acut
phase
sera
sampl
time
convalesc
phase
sera
seem
ac
count
differ
final
antibodi
level
also
consid
degre
upper
respiratori
gener
ill
among
pa
tient
group
patient
serolog
evid
group
infect
gave
accur
histori
nine
report
associ
upper
respiratori
fection
conjunct
contrast
one
adenoviru
type
patient
group
exhibit
sign
symptom
upper
respiratori
infect
differ
enc
signific
p
test
thu
group
nonepidem
adenoviru
infect
afflict
upper
respiratori
infect
fection
necessarili
respons
significantli
higher
serolog
titer
fact
signific
relationship
tween
presenc
upper
respiratori
infect
serolog
respons
equal
exceed
tabl
neg
correl
held
true
chang
homolog
heterolog
viru
titer
therefor
explan
higher
serum
titer
patient
group
infect
may
relat
directli
concomit
upper
respiratori
infect
compar
sensit
two
commonli
employ
serolog
test
tabl
hemagglutinationinhibit
test
demonstr
fourfold
rise
mani
case
complementfix
test
fail
show
signific
chang
henc
primari
de
pendenc
usual
complementfix
hexonantigen
test
would
result
fewer
posit
diagnos
even
acut
infec
tion
ancillari
laboratori
studi
nonepidem
patient
microscop
examin
conjunctiv
smear
patient
routin
bacteri
cultur
taken
patient
plu
ten
individu
cultur
five
patient
show
coagulaseposit
staphylococci
patient
variou
diagnos
adenoviru
type
epi
demic
keratoconjunct
adenoviru
type
pharyngoconjunctiv
fever
herp
sim
plex
kerat
case
chronic
fac
titiou
conjunct
smear
help
case
herpet
infect
three
patient
herp
simplex
one
herp
zoster
twentyeight
patient
show
sign
kerat
ill
chronic
subepitheli
infiltr
examin
one
month
resolut
ill
experienc
degre
decreas
visual
acuiti
well
remain
patient
also
infect
first
wave
epidem
seen
time
subepitheli
infiltr
peak
geometr
mean
hemagglutinationinhibit
titer
mer
group
residu
infiltr
rang
data
un
affect
group
geometr
mean
titer
rang
differ
signific
p
collect
sera
interv
examin
similar
patient
part
epidem
group
serolog
test
exactli
carri
nonepidem
group
often
done
simultan
estim
maximum
percent
cornea
epitheli
subepitheli
infiltr
titer
chang
significantli
fourfold
observ
period
compar
tabl
analysi
corneal
diseas
group
compos
five
patient
adenoviru
type
patient
adenoviru
type
infect
group
contain
patient
adenoviru
type
one
adenoviru
type
adenoviru
data
concern
corneal
involv
ment
antibodi
level
group
compil
tabl
compar
tabl
analysi
x
test
show
sever
sig
nific
correl
first
number
eye
involv
corneal
chang
differ
significantli
two
group
group
five
patient
involv
ment
seven
one
eye
four
eye
affect
group
one
patient
without
corneal
chang
three
pa
tient
singl
eye
involv
nine
patient
eye
involv
x
df
factor
vol
number
eye
use
antibodi
level
compar
adenoviru
infect
group
signifi
cant
differ
note
level
doubli
involv
patient
four
one
eye
three
corneal
volvement
level
one
pa
tient
show
infiltr
eye
six
singl
eye
involv
three
ocu
lar
involv
differ
number
patient
three
categori
prove
statist
signific
x
p
correl
degre
corneal
volvement
antibodi
level
also
car
rie
differ
two
group
number
patient
central
lesion
vs
peripher
lesion
cornea
reflect
patient
decreas
visual
acuiti
tabl
devis
comparison
two
group
term
foldris
antibodi
titer
fig
ure
foldris
reflect
rate
antibodi
product
well
amount
antibodi
evidenc
graph
respons
two
group
almost
diametr
oppos
foldris
titer
group
patient
pro
gressiv
less
corneal
involv
chang
titer
group
patient
show
progress
corneal
infiltra
tion
howev
final
level
antibodi
achiev
lower
group
compar
tabl
similar
differ
two
group
note
level
corneal
infiltr
two
patient
group
infiltr
involv
corneal
surfac
area
group
six
patient
affect
way
x
df
p
final
age
factor
differentiat
ing
two
group
averag
age
group
patient
year
group
patient
averag
year
differ
statist
signific
df
comparison
percent
corneal
involv
foldris
antibodi
titer
among
patient
infect
group
av
av
adenovirus
r
repres
correl
coeffici
leastsquar
line
calcul
fit
data
patient
least
fourfold
rise
includ
group
rise
titer
heterolog
vi
ruse
observ
group
infec
tion
thu
patient
infect
adeno
viru
type
group
signific
chang
titer
agent
occur
well
smaller
chang
relat
type
tabl
howev
rise
heterolog
titer
consist
seen
patient
group
infect
exampl
adenoviru
type
infect
produc
rise
relat
viral
type
group
seri
reflect
higher
heterolog
averag
titer
tabl
particular
note
tendenc
heterolog
respond
within
famili
group
one
famili
blood
rel
show
chang
titer
sever
group
subtyp
adeno
viru
type
infect
howev
spous
one
member
expos
viru
serolog
chang
adenoviru
type
alon
homolog
respond
american
journal
ophthalmolog
octob
observ
patient
keratoconjunct
caus
studi
tabl
adenoviru
patient
form
homogen
group
lent
selv
statist
analysi
herp
group
larg
eight
herp
simplex
two
herp
zoster
two
possibl
mix
herp
simplexzost
three
presum
cytomegaloviru
heterogen
term
acut
chronic
ill
treatment
var
iou
antivir
drug
corticosteroid
poor
serolog
respons
variabl
tori
followup
factor
occur
among
patient
adenoviru
number
patient
met
criteria
variou
analys
often
differ
one
test
anoth
term
treatment
howev
almost
patient
adenoviru
requir
therapi
topic
vasocon
strictor
antibiot
two
patient
one
group
requir
corticosteroid
symptomat
lief
institut
achiev
maximum
corneal
score
analysi
tearsocular
extern
secr
tion
tear
analyz
ten
patient
gener
low
antibodi
titer
four
patient
serolog
diagnos
herpet
infect
repres
chronic
current
keratoconjunct
keratouv
one
patient
disci
form
kerat
uveiti
detect
tearborn
neutral
antibodi
herp
simplex
serum
titer
howev
greater
simul
taneou
neutral
test
one
patient
show
tear
antibodi
herp
zoster
se
rolog
chang
consist
simplex
whether
repres
true
simultan
infect
presenc
cross
reaction
determin
two
patient
high
titer
coronaviru
extern
secret
upper
respiratori
infect
produc
antibodi
tear
may
repres
kind
relationship
predomin
immunoglobulin
speci
tear
iga
agreement
pre
viou
work
howev
made
tempt
prove
measur
hemagglutinationinhibit
serum
neutral
antibodi
uniqu
iga
discuss
patient
second
part
studi
seen
nonepidem
time
period
case
kerat
vari
etiolog
tabl
observa
tion
agre
previou
studi
de
scribe
similar
varieti
viral
agent
sponsibl
epidem
keratoconjunct
kerat
behavior
individu
viral
infec
tion
also
conform
expect
pattern
thu
group
adenovirus
caus
upper
respiratori
gener
ill
less
kerat
group
infect
herp
virus
caus
sever
kerat
keratouv
clinic
ill
cor
relat
poorli
serolog
chang
anti
bodi
titer
also
encount
difficulti
cultur
viru
seven
ten
day
symptom
report
epidem
keratoconjunct
probabl
true
mani
viral
syndrom
like
other
also
found
hemagglutinationinhibit
test
supe
rior
complementfix
serum
diag
nostic
procedur
adenoviru
infect
procedur
gave
consist
result
tear
differ
extent
corneal
involv
observ
group
infect
correl
indic
group
virus
produc
lower
level
specif
antibodi
titer
despit
longer
time
interv
collect
acut
convalesc
sera
induc
corneal
diseas
affect
indi
vidual
data
suggest
higher
anti
bodi
titer
group
protect
cornea
support
examin
keratocon
junctiv
epidem
adenoviru
type
group
viru
latter
patient
rang
antibodi
observ
somewhat
higher
nonepidem
group
reason
differ
readili
appar
lie
test
differ
sinc
set
sera
ex
amin
ident
condit
often
simultan
import
howev
rang
corneal
involv
ment
singl
viral
agent
patient
higher
antibodi
titer
ex
perienc
less
corneal
involv
usual
virul
agent
corneal
infiltr
may
repres
pattern
infect
antibodi
spons
certainli
one
viral
type
caus
pattern
shown
nonepidem
group
also
viru
caus
differ
degre
involv
epi
demic
studi
perhap
depend
level
antibodi
illicit
infect
sinc
delay
hypersensit
spe
cific
assay
elev
humor
anti
bodi
epidem
group
nonepidem
group
patient
may
reflect
higher
degre
oi
overal
immun
cellular
immun
may
chief
deterr
corneal
di
eas
howev
system
antibodi
alon
may
protect
cornea
even
fellow
eye
sever
involv
whether
humor
cellular
nonepidem
epidem
group
patient
display
reason
similar
pattern
protect
correl
high
antibodi
titer
specul
pathogenesi
subepitheli
infiltr
studi
immunecomplex
diseas
instanc
rheu
matoid
arthriti
aleutian
mink
diseas
antigenantibodi
complex
blood
vessel
wall
attract
complement
inflamma
tori
cell
caus
damag
complex
made
persist
maintain
ing
low
titer
antibodi
diseas
may
complet
elimin
rais
titer
cornea
similar
collagen
ti
sue
wall
blood
vessel
tissu
absorb
certain
antigen
therefor
seem
feasibl
viral
par
ticl
might
bound
stromal
collagen
form
complex
low
level
antibodi
diffus
within
cornea
therebi
act
nidu
inflamm
subsequ
fixat
complement
attract
flammatori
cell
complet
subepitheli
infiltr
seen
slitlamp
microscopi
corticosteroid
would
disrupt
inflammatori
respons
would
remov
com
plex
henc
discontinu
drug
would
allow
inflammatori
cell
reappear
similar
set
circumst
propos
pathogenesi
stromal
diseas
herp
simplex
kerat
base
supposit
one
may
con
clude
sometim
perman
visual
damag
observ
epidem
keratoconjunct
might
decreas
elimin
enhanc
immun
respons
fect
patient
perhap
acut
fection
individu
suffer
follicular
conjunct
without
kerat
epidem
keratoconiunct
caus
adenoviru
type
remain
pa
tient
keratoconjunct
produc
sever
differ
virus
includ
herp
simplex
adenovirus
type
other
posit
viral
cultur
difficult
obtain
first
week
ill
viral
infect
serolog
test
far
success
identifi
caus
agent
hemagglutinationinhibit
test
adenoviru
infect
prove
fast
accur
sensit
serolog
test
among
epidem
nonepidem
adenoviru
group
de
gree
corneal
involv
infect
appear
correl
level
anti
bodi
infecti
agent
patient
low
antibodi
titer
sever
kerat
high
titer
correl
true
epidem
nonepidem
patient
